Takuro Saiki
Overview
Explore the profile of Takuro Saiki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsumoto Y, Higuchi A, Shiba M, Sasaki K, Saiki T, Honma Y, et al.
Palliat Med Rep
. 2023 Jul;
4(1):169-174.
PMID: 37483881
Background: Palliative chemotherapy is commonly used for advanced cancer patients. The timing of chemotherapy termination is crucial for efforts to maintain quality of life. Patients And Methods: This retrospective study...
2.
Saiki T, Ogata G, Sawamura S, Asai K, Razvina O, Watanabe K, et al.
Heliyon
. 2023 May;
9(5):e15963.
PMID: 37234605
On-site monitoring of plasma drug concentrations is required for effective therapies. Recently developed handy biosensors are not yet popular owing to insufficient evaluation of accuracy on clinical samples and the...
3.
Nakano M, Shimada Y, Matsumoto Y, Saiki T, Zhou Q, Sasaki K, et al.
Clin J Gastroenterol
. 2022 Feb;
15(2):413-418.
PMID: 35133626
Neuroendocrine neoplasms of the colon and rectum are colorectal epithelial neoplasms with neuroendocrine differentiation. A platinum regimen used for small cell lung cancer is the currently recommended chemotherapy for gastroenteropancreatic ...
4.
Sawamura S, Ogata G, Asai K, Razvina O, Ota T, Zhang Q, et al.
Front Pharmacol
. 2021 May;
12:633505.
PMID: 34012393
Hearing loss affects >5% of the global population and therefore, has a great social and clinical impact. Sensorineural hearing loss, which can be caused by different factors, such as acoustic...
5.
Sakai Y, Zhou Q, Matsumoto Y, Saiki T, Moriyama M, Toyama A, et al.
Oncology
. 2020 Aug;
98(11):771-778.
PMID: 32829332
Introduction: Because of the increasing age of the general population, there is an increasing number of older patients with lung cancer. Cancer chemotherapy often causes severe hematological toxicity in older...
6.
Matsumoto Y, Kimura K, Zhou Q, Sasaki K, Saiki T, Moriyama M, et al.
Mol Clin Oncol
. 2019 Sep;
11(4):383-389.
PMID: 31475066
The number of older patients with esophageal cancer (EC) is increasing due to the population aging and increasing life expectancy. However, no optimal treatment strategy for older patients with EC...
7.
Sasaki K, Zhou Q, Matsumoto Y, Saiki T, Moriyama M, Saijo Y
Intern Med
. 2019 Jun;
58(19):2791-2795.
PMID: 31243213
Two patients underwent hemodialysis. Case 1 with stage IV gastric cancer was treated with reduced doses of capecitabine (1,000 mg/m/day, days 1 to 14) and oxaliplatin (65 mg/m, day 1)....